NCT01224665
Clinical Trial Information
Trial Number: NCT01224665 (ClinicalTrials.gov)
Disease Type:
- Urothelial Tract Neoplasm - Miscellaneous
- Urothelial Tract Neoplasm - Urothelial Tract/Bladder Cancer
Trial Title:
"A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer"
Study ID:
S1011
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01224665-D3 | The toxicity dataset contains event-level information (one row per patient per adverse event experienced on trial NCT01224665).There are two other datasets associated with PubMed ID: 39589370. |
| NCT01224665-D2 | The ineligibility dataset contains patient-level data (one row per patient) for patients that were deemed ineligible at Step 2 randomization on trial NCT01224665. It includes reasons for ineligibility. There are two other datasets associated with PubMed ID: 39589370. |
| NCT01224665-D1 | This dataset contains the results reported for trial NCT01224665 in the New England Journal of Medicine (PubMed ID: 39589370). The clinical dataset contains patient-level data (one row per patient), including evaluability, treatment, demographic, baseline information, and assessment data for eligible patients (Step 2: randomization). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®